这篇论文用EB-VAE同时预测肿瘤体积变化和患者脱落时间,还整合了基因信息,比传统模型更灵活,在黑色素瘤和乳腺癌数据上验证有效。
该研究提出多模态经验贝叶斯变分自编码器(EB-VAE)框架,在肿瘤生长数据上联合建模纵向肿瘤体积轨迹与脱落时间事件。框架通过经验贝叶斯先验正则化潜在个体效应,并引入风险模型处理信息性脱落。在皮肤黑色素瘤和乳腺癌实验中,混合半机制解码器恢复的治疗参数与非线性混合效应估计一致。遗传条件改进了个体预测,稳定性选择识别出BRAF、NRAS、NF1和MDM2等生物相关遗传指标。
Multimodal Empirical Bayes Variational Autoencoders for Joint Longitudinal and Time-to-Event Modeling
Longitudinal tumor measurements, dropout information, and genetic covariates provide complementary information about treatment response, but integrating these data sources within a single population modeling framework remains challenging. We extend the empirical Bayes variational autoencoder (EB-VAE) framework to joint longitudinal and time-to-event modeling and evaluate it on tumor growth data. The framework represents inter-individual variability using latent individual effects regularized by a covariate-conditioned empirical Bayes prior, while a decoder maps these latent effects to tumor-volume trajectories. To account for informative dropout, the decoder was augmented with a hazard model, yielding joint predictions of tumor growth and time to dropout. We further compared fully neural and hybrid semi-mechanistic decoder formulations and incorporated genomic covariates through a genetics-conditioned prior adaptation. The hybrid decoder recovered treatment-effect parameters broadly consistent with previously reported nonlinear mixed-effects estimates, while achieving prior predictive performance comparable to the neural decoder. The joint model reproduced both tumor-volume distributions and dropout patterns in held-out individuals, and genetic conditioning improved individual-level prior predictions in both cutaneous melanoma and breast cancer experiments. Stability selection identified several biologically plausible genetic indicators, including alterations in BRAF, NRAS, NF1, and MDM2. These results demonstrate that EB-VAE provides a flexible probabilistic framework for combining neural dynamics, mechanistic structure, time-to-event modeling, and high-dimensional covariates in pharmacometric applications.